Clin Mol Hepatol.
2025 Apr;31(2):e125-e127. 10.3350/cmh.2024.1087.
Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
- Affiliations
-
- 1Department of Gynecology, HuangJiahu Hospital of Hubei University of Chinese Medicine, Hubei, China
- 2Department of Oncology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei, China
- 3Department of Internal Medicine of Chinese Medicine, HuangJiahu Hospital of Hubei University of Chinese Medicine, Hubei, China
- KMID: 2567002
- DOI: http://doi.org/10.3350/cmh.2024.1087
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
- Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
- Correspondence to letter to the editor 2 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
- Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
- Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
